Series A - Vaderis Therapeutics

Series A - Vaderis Therapeutics

Investment Firm

Overview

Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.

Announced Date

Jan 01, 2020

Funding Type

Series A

Highlights

Location

Switzerland, Europe

Social

N/A

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMedicxi

Round Details and Background

Vaderis Therapeutics raised $18598980 on 2020-01-01 in Series A

Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2020
Series A - Vaderis Therapeutics
1-18.6M

Recent Activity

There is no recent news or activity for this profile.